Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
2.820
+0.150 (5.62%)
Dec 24, 2024, 1:00 PM EST - Market closed
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $949.12 million as of December 24, 2024. Its market cap has increased by 225.94% in one year.
Market Cap
949.12M
Enterprise Value
411.17M
1-Year Change
225.94%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $949.12M, an increase of 443.97%. That is a compound annual growth rate of 47.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2024 | 898.63M | 171.81% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Liquidia | 930.16M |
| Poseida Therapeutics | 921.55M |
| Pacira BioSciences | 886.53M |
| Aveanna Healthcare Holdings | 883.04M |
| AMN Healthcare Services | 880.26M |
| Phibro Animal Health | 876.09M |
| LENZ Therapeutics | 859.82M |
| ArriVent BioPharma | 853.21M |